title: Structure-based inhibition of protein-protein interactions.
abstract: Protein-protein interactions (PPIs) are emerging as attractive targets for drug design because of their central role in directing normal and aberrant cellular functions. These interactions were once considered "undruggable" because their large and dynamic interfaces make small molecule inhibitor design challenging. However, landmark advances in computational analysis, fragment screening and molecular design have enabled development of a host of promising strategies to address the fundamental molecular recognition challenge. An attractive approach for targeting PPIs involves mimicry of protein domains that are critical for complex formation. This approach recognizes that protein subdomains or protein secondary structures are often present at interfaces and serve as organized scaffolds for the presentation of side chain groups that engage the partner protein(s). Design of protein domain mimetics is in principle rather straightforward but is enabled by a host of computational strategies that provide predictions of important residues that should be mimicked. Herein we describe a workflow proceeding from interaction network analysis, to modeling a complex structure, to identifying a high-affinity sub-structure, to developing interaction inhibitors. We apply the design procedure to peptidomimetic inhibitors of Ras-mediated signaling.
authors.affiliation: Department of Chemistry, New York University, 100 Washington Square East, New York, NY 10003, United States.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Watkins
authors.affiliation: Department of Chemistry, New York University, 100 Washington Square East, New York, NY 10003, United States. Electronic address: arora@nyu.edu.
authors.forename: Paramjit S
authors.initials: PS
authors.lastname: Arora
mesh_terms: D015195:Drug Design; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D057786:Peptidomimetics / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D011485:Protein Binding / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects*; D018631:ras Proteins / Q000378:metabolism*
chemical_list: D057786:Peptidomimetics; D018631:ras Proteins
keywords: Computational tools; Inhibitor design; Peptidomimetic; Protein structure; Protein-protein interaction